Briefly explained (TL;DR)
Joint pain is one of the most common symptoms of menopause: In an analysis of 321 studies, an average of 65.4% of middle-aged women reported joint and muscle complaints (self-reported, evidence quality according to authors suboptimal). Whether estrogen deficiency is the primary cause is not definitively clear; osteoarthritis and rheumatoid arthritis must be ruled out.
Exercise and strength training have the strongest evidence. A draft guideline (2026) suggests that hormone therapy can be offered for newly occurring, non-specific joint complaints with hormonal indicators – consensus-based, not standard.
Supplements are not a pain solution: Vitamin D and Omega-3 showed no benefit for knee pain in a study of 1,398 people; collagen yields mixed results; glucosamine is controversial. Warm, swollen joints or prolonged morning stiffness require medical investigation.
Important medical disclaimer
This article is for informational purposes only and does not replace medical diagnosis, advice, or treatment. Joint pain can have many causes, including inflammatory diseases that require early therapy.
Hormone therapy and prescription medications must be decided exclusively under medical supervision. The guideline recommendation E 2.15 comes from a consultation version (draft) and may change before final adoption.
Joint pain in menopause: How common is it really?
Very common: In an analysis of 321 studies involving a total of 482,067 middle-aged women, an average of 65.4% reported joint and muscle complaints. This placed them at the top of all menopausal symptoms surveyed, ahead of exhaustion, hot flashes, and sleep problems. The research team led by Fang analyzed data from 2000 to March 2023 for this purpose.
The authors acknowledge the limitations themselves: most studies were based on self-reports and were cross-sectional surveys, the variance between studies remained unexplained, and the overall quality of the evidence was classified as suboptimal by the GRADE process. The figure therefore shows how widespread the symptom complex is, not how severe it is in individual cases.
A smaller, but more transition-focused meta-analysis reaches a similar conclusion. Lu and colleagues summarized 16 studies involving approximately 5,836 women from twelve countries, predominantly cross-sectional studies. Among perimenopausal women, the pooled prevalence of chronic muscle or joint pain was 71% (95% CI 64–78%).
Perimenopausal women had a higher risk of such pain than premenopausal women (OR 1.63; 1.35–1.96). No clear difference was found between peri- and postmenopause (OR 1.07; 0.95–1.20). For moderate to severe pain, postmenopausal women were more affected than premenopausal (OR 1.45) and perimenopausal women (OR 1.40) in three studies each. The authors acknowledge selection bias, misclassification via self-reporting, and high heterogeneity.
Two things can be concluded from this. First, joint pain in this phase of life is not a marginal phenomenon, and those who notice it are highly unlikely to be alone. Second, "joint and muscle complaints" in the studies does not mean "joint disease": a symptom was measured, and very different causes can lie behind that symptom. Exactly this distinction is the core of the following sections.
What estrogen has to do with joints – and what is not proven
Estrogen acts on joint tissue, but clear proof that declining estrogen causes menopausal joint pain is currently lacking. The review by Roman-Blas and colleagues describes that estrogen receptors are present in cartilage, synovium, and bone; the subtype ERβ predominates in cartilage, spongy bone, and the synovial membrane. Joints are therefore not hormone-free zones.
As epidemiological indicators, the paper notes that radiographically generalized osteoarthritis is three times more common in women aged 45–64 than in men of the same age, and that in 64% of women with knee osteoarthritis, symptoms began in perimenopause or within five years after natural menopause. These are observations, not evidence of cause and effect.
The authors themselves write that the influence of estrogen deficiency on cartilage remains unclear. Studies in animals and humans have yielded partially contradictory results, and they describe the effect of estrogen therapy on the development and progression of osteoarthritis as unresolved.
In 2024, Wright and colleagues proposed the term "musculoskeletal syndrome of menopause" in the journal Climacteric. This refers to the totality of musculoskeletal signs associated with estrogen loss: joint pain (arthralgia), muscle loss, decreasing bone density, and the progression of osteoarthritis. According to the abstract, more than 70% of women develop musculoskeletal symptoms, with 25% experiencing limitations in daily life. This is a narrative review, not a new study; the term provides a framework, it does not prove a mechanism.
→ Source: Wright VJ et al. – The musculoskeletal syndrome of menopause, Climacteric (2024)
Estrogen is therefore a plausible, but not the only, player. IQWiG information on osteoarthritis lists age over 40, previous joint injuries, obesity, heavy physical work, and weak thigh muscles as risk factors, among others. In the same stage of life when estrogen levels drop, several of these factors often converge. Our article on muscle loss in menopause explains why muscle loss plays its own role here.
→ Source: IQWiG – Osteoarthritis, gesundheitsinformation.de (as of 06/25/2025)
Arthralgia, osteoarthritis, or rheumatoid arthritis: How to spot the difference
Patterns and signs of inflammation are crucial: Osteoarthritis usually hurts during exertion and after periods of rest, while rheumatoid arthritis makes joints warm, swollen, and stiff for a long time in the morning. "Arthralgia" simply means joint pain without specifying the cause. The guideline we discuss below uses the term "non-specific joint complaints" as a collective term.
IQWiG health information on rheumatoid arthritis describes typical early signs: warm, swollen, and painful joints, morning stiffness lasting longer than an hour, muscle weakness, fatigue, and malaise.
Usually, the same joints are affected on both sides of the body, often initially the knuckle and toe joints. According to IQWiG, the disease usually develops after age 50; women are 2–3 times more likely to be affected than men. This overlaps chronologically with menopause, which is why a closer look is worth it.
→ Source: IQWiG – Rheumatoid Arthritis, gesundheitsinformation.de (as of 11/15/2023)
In the case of osteoarthritis, IQWiG describes "start-up pain," such as when getting up after sitting for a long time, which decreases with movement, and a gradual progression over many years. The most frequently affected areas are the knees, hips, finger joints, and facet joints of the spine. Morning stiffness lasting longer than 30 minutes, according to IQWiG, points more toward rheumatoid arthritis than osteoarthritis. IQWiG's duration data varies between 30 minutes and one hour depending on the page; as a rule of thumb: the longer the stiffness, the more likely the joint needs rheumatological evaluation.
→ Source: IQWiG – Osteoarthritis, gesundheitsinformation.de (as of 06/25/2025)
| Feature | Non-specific joint complaints (Arthralgia) | Osteoarthritis | Rheumatoid arthritis |
|---|---|---|---|
| Onset | New during the hormonal transition, often without a clear trigger | Gradual over many years, typically after age 40 | Usually after age 50; women 2–3 times more frequent than men |
| Pain pattern | Pain in one or more joints, sometimes muscles; fluctuating | Exertion pain and start-up pain after rest; often improves with movement | Also at rest, often with swelling and heat |
| Morning stiffness | Not uniformly defined; persistent stiffness over 30 minutes should be clarified | Short; stiffness over 30 minutes suggests rheumatism (IQWiG) | Over 30 minutes to over an hour |
| Affected joints | Knee, hip, fingers, or other joints; often changing | Knees, hips, finger joints, spine | Usually symmetrical: knuckles and middle finger joints, toe joints |
| Signs of inflammation | Absent by definition | Usually absent (irritation possible) | Warm, swollen joints, fatigue, exhaustion |
| Who performs the diagnosis? | General practitioner or gynecologist | General practitioner, orthopedist | Rheumatologist |
The table summarizes information from IQWiG and supplements the column on non-specific joint pain as a classification provided by the editorial team; it does not replace a medical examination. Multiple conditions may be present simultaneously.
When joint pain during menopause should be medically investigated
As soon as joints are warm, swollen, or red, morning stiffness lasts a long time, or pain increases at night and while at rest, a doctor should take a look. New, significant weakness, fever, or exhaustion in combination with joint pain are also reasons for a prompt appointment. This is not alarmist: inflammatory joint diseases are treatable, and they are easier to manage when detected early.
In cases of suspected rheumatoid arthritis, IQWiG explicitly recommends seeing a specialist in rheumatology. If you are unsure, start with your general practitioner or gynecologist and get a referral if needed. A short symptom diary over two to three weeks is helpful: Which joints, on one side or both, how long does morning stiffness last, with or without swelling?
→ Source: IQWiG – Rheumatoid Arthritis, gesundheitsinformation.de (as of Nov 15, 2023)
Important note on warning signs
A single hot, severely swollen joint accompanied by fever, or intense joint pain following a fall, does not belong in a guidebook but requires acute medical attention.
This article does not replace a diagnosis. It helps you ask the right questions.
Movement and strength training for joint pain: The best-supported measure
Regular exercise is the measure with the most reliable data, even if the effect on pain remains moderate. The Cochrane team led by Lawford evaluated 139 studies with 12,468 participants with knee osteoarthritis. Compared to no treatment or usual care, exercise improved pain by an average of 13.14 points on a scale of 0 to 100 (95% CI 10.36–15.91), and function by 12.53 points.
Compared to a sham treatment (attention control), the improvement was 8.70 points (5.70–11.70), and as a supplement to another treatment, exercise provided an additional 10.43 points (8.06–12.79). The authors rate the certainty of the evidence as mostly low for pain, and moderate for the additional effect to other measures and for function. Their conclusion: Exercise likely improves pain, function, and quality of life in the short term, but the clinical significance is uncertain.
Important for context: This data comes from people with knee osteoarthritis, not specifically from women in menopause. However, it cannot be simply dismissed, as osteoarthritis is one of the common causes of joint pain at this age. US guidelines from the American College of Rheumatology and Arthritis Foundation (2019) explicitly recommend movement, Tai Chi, and self-management programs as a foundation, as well as weight loss; they conditionally recommend balance training with or without strength training.
In practice, this means: joint-friendly endurance activities like cycling, swimming, or brisk walking, plus two strength sessions per week with moderate weights so that the muscles relieve the joints. The article on muscle loss during menopause explains why strength training is useful during this life phase anyway. If you are hesitating due to aching joints, the article on gentle training starting at 40 offers a low-impact entry point.
Hormone therapy (MHT) for joint pain: What guidelines and studies say
Hormone replacement therapy, now usually called "menopausal hormone therapy" (MHT) in guidelines, is not a standard treatment for joint pain. According to the current draft guideline, it can be offered if joint symptoms occur newly within the context of menopause and there are indications of a hormonal cause. This is an open, consensus-based recommendation, not a treatment standard.
The wording in the 2026 consultation draft of the S3-guideline "Peri- and Postmenopause – Diagnostics and Interventions" (AWMF 015-062) in recommendation E 2.15 is: "If non-specific joint pain occurs newly in women during the menopausal transition and there are indications of a hormonal cause, an MHT can be offered, provided there are no contraindications." The recommendation is marked as consensus-based (100% consensus). In the excerpt we read, this was not followed by a derivation citing studies.
There are two limitations. It is a consultation version, i.e., a draft that can still change before adoption. And "can be offered" is a weaker formulation than for hot flashes, for which the Menopause Society describes hormone therapy as the most effective treatment.
→ Source: AWMF 015-062 – Short version 2026 (Consultation draft) of the S3-guideline Peri- and Postmenopause
The study basis is thin but exists. In the randomized Women's Health Initiative (estrogen alone, women after hysterectomy), 10,739 women received 0.625 mg of conjugated estrogens daily or a placebo; in a subgroup of 1,062 women, joint pain and swelling were recorded via questionnaire. At the beginning, about 77% reported joint pain.
After one year, the proportion in the estrogen group was 76.3% compared to 79.2% in the placebo group (p = 0.001); the difference remained until year 3. Joint swelling, however, was slightly more common in the estrogen group (42.1% vs. 39.7%; p = 0.02).
Chlebowski and colleagues speak of a "moderate but persistent" reduction in the frequency of joint pain. Given a starting level of around 77%, this explains why this effect feels more like a decrease in frequency than being pain-free. Please note: The study examined estrogen without progestogen in women without a uterus, symptoms were self-reported, and it concerned women post-menopause, not the transition phase.
The Menopause Society (formerly NAMS) describes hormone therapy in its 2022 position statement as the most effective treatment for vasomotor symptoms and genitourinary syndrome, and as a measure against bone loss and fractures. Joint pain does not appear in the summary as a separate treatment indication.
For women under 60 years or within ten years of menopause without contraindications, the benefit-risk ratio is considered favorable by the panel. Starting later increases the risks for coronary heart disease, stroke, thrombosis, and dementia. Treatment should be decided on an individual basis.
In practice, this means: anyone suffering from hot flashes, sleep disorders, or other menopausal symptoms anyway and who additionally notices new joint pain has a good reason to raise the hormone question in their gynecological practice. Those who have joint pain exclusively should first have it clarified whether osteoarthritis or an inflammatory disease is behind it. What studies and guidelines say about hormone therapy for other symptoms can be found in the article on hot flashes during menopause.
Medication for joint pain: What is common and what matters
For osteoarthritis, over-the-counter painkillers like ibuprofen demonstrably relieve symptoms, but they do not treat the cause. IQWiG health information explicitly names medications like ibuprofen as effective against osteoarthritis pain; the US guideline from the ACR and Arthritis Foundation strongly recommends oral non-steroidal anti-inflammatory drugs (NSAIDs) for temporary pain relief and cortisone injections into the joint for short-term benefit.
This applies to osteoarthritis. In the case of rheumatoid arthritis, treatment is in the hands of a rheumatologist, and that involves more than just pain relief. Painkillers have side effects and interactions that depend on personal history. Duration and dose should therefore be coordinated with a doctor or pharmacist, especially in cases of pre-existing stomach, kidney, or cardiovascular conditions, or if taking blood thinners.
→ Source: IQWiG – Osteoarthritis, gesundheitsinformation.de (as of June 25, 2025) · Buelt A, Narducci DM – Osteoarthritis Management: Updated Guidelines from the ACR and Arthritis Foundation, American Family Physician (2021)
Dietary supplements for joint pain during menopause: What studies show
There is currently no reliable evidence for any of the common substances that they alleviate joint pain during menopause. For vitamin D and omega-3, large studies on knee pain are negative; for collagen, the situation is mixed; for glucosamine and chondroitin, the guidelines contradict each other. The following overview separates what has been tested from what is merely claimed.
Vitamin D and Omega-3: No benefit for knee pain after five years
The most meaningful test to date is a sub-study of the VITAL study. MacFarlane and colleagues followed 1,398 adults with frequent, chronic knee pain (mean age 67.7 years, 66% women) over an average of 5.3 years. They received 2,000 IU of vitamin D3 daily, 1 g of marine omega-3 fatty acids, both, or a placebo.
The pain score in the WOMAC index did not differ between the verum and placebo groups at any point; stiffness, function, knee replacement surgeries (hazard ratio 0.97 for vitamin D, 0.99 for omega-3), and painkiller consumption also remained unchanged.
This statement applies to knee pain in predominantly older participants and not specifically to the transition phase. Furthermore, it does not say anything about whether correcting a medically diagnosed vitamin D deficiency has other benefits, such as for bones. This is a separate topic in this life phase: How calcium, vitamin D, K2, and strength training interact is described in the article Preventing Osteoporosis Starting at 50; dosage questions are clarified in the Vitamin D3 dosage check. Regarding the role of omega-3 overall, the Omega-3 study check is worth a look.
Collagen: Mixed results in osteoarthritis, no specific menopause study found
In studies on osteoarthritis, collagen peptides show effects on questionnaire values, but not for every individual metric. García-Coronado and colleagues summarized randomized, placebo-controlled studies: The total WOMAC score decreased by an average of 8.00 points (95% CI −13.04 to −2.95), stiffness by 0.41 points, and the visual pain scale by 16.57 points. Conversely, the sub-scores for pain and function in the WOMAC did not differ significantly from the placebo.
This presents a mixed picture, and it concerns people with osteoarthritis. In our research, we found no study that tested collagen specifically for joint pain during menopause. What collagen can do for skin and connective tissue during this phase is covered in the article Menopause and skin aging; amounts and intake are explained in the Collagen dosage check.
Glucosamine and Chondroitin: Guidelines contradict each other
Glucosamine and chondroitin are the most well-known joint duo, and the evidence remains inconsistent. The US center NCCIH cites the GAIT study with 572 participants over two years as a key study: the joint space width did not differ between the placebo and all other groups. An analysis of 29 studies from 2018 showed pain relief for each substance individually, but not for the combination.
The contradiction between professional societies matches this: the ACR and Arthritis Foundation strongly advised against glucosamine in 2019, while the American Academy of Orthopaedic Surgeons wrote in 2021 that it “may be helpful” amid inconsistent evidence. According to the NCCIH, large studies found no major safety issues; glucosamine can raise blood sugar, and both substances can increase the risk of bleeding when taking warfarin. Our detailed study checks on this: Glucosamine and Chondroitin for Joint Pain and Effects, Dosage, and Studies on Osteoarthritis.
MSM, Turmeric, Ginger: Independent Fact-Checks Instead of Blanket Promises
The following also applies to MSM, turmeric, and ginger: if you want to try them, you should know the state of the evidence before purchasing. We have published our own fact-checks on these, which we will not repeat here: MSM for Joints and Connective Tissue, Turmeric Capsules Fact-Check, and Ginger for Inflammation.
| Supplement | What was tested | Result | Assessment |
|---|---|---|---|
| Vitamin D3 (2,000 IU/day) | VITAL sub-study, 1,398 adults with chronic knee pain, 5.3 years | WOMAC pain unchanged vs. placebo; knee replacement HR 0.97 (0.77–1.22) | No proven pain benefit; bone health is a separate issue |
| Omega-3 (1 g marine n-3/day) | Same study, second factor | WOMAC pain unchanged; knee replacement HR 0.99 (0.79–1.24) | No proven pain benefit for knee pain |
| Collagen peptides | Meta-analysis of randomized placebo studies for osteoarthritis | Total WOMAC −8.00 (−13.04 to −2.95); VAS −16.57; WOMAC pain and function not significant | Mixed picture; no menopause-specific study found |
| Glucosamine / Chondroitin | GAIT study (572 people, 2 years) and meta-analysis of 29 studies (NCCIH) | Joint space unchanged; pain relief individual, not combined | Conflicting guidelines (ACR 2019 against, AAOS 2021 “may be helpful”) |
All figures are derived from the original sources linked above. The studies primarily examined osteoarthritis or knee pain in older adults, not specifically women in menopause.
Home Remedies and Natural Approaches: Heat, Weight, and Diet
As for “natural” measures, heat, physical activity, and—in cases of excess weight—weight loss are best supported, while herbal remedies remain uncertain. The ACR guideline recommends heat applications and acupuncture conditionally, with modest benefit. The IQWiG describes that a weight loss of at least 5%, preferably 10%, alleviates osteoarthritis symptoms; the ACR rates weight loss as a strong recommendation.
→ Source: Buelt A, Narducci DM – Osteoarthritis Management: Updated Guidelines from the ACR and Arthritis Foundation, American Family Physician (2021) · IQWiG – Osteoarthritis, gesundheitsinformation.de (As of 25.06.2025)
Heat (cherry stone pillows, warm baths) and gentle mobilization are low-risk and easy to try. For those considering home remedies like quark wraps, compresses, or ointments: we did not find any robust studies on joint pain in menopause for such applications in our research, but they can still have their place as a wellness measure, provided they do not replace medical clarification and physical activity.
There is a lot of opinion and little hard data on nutrition. Dr. Andrew Weil, a physician and proponent of integrative medicine, believes the nightshade elimination diet is barely supported by evidence, but recommends an anti-inflammatory diet with fatty fish, flaxseeds, walnuts, colorful vegetables and fruits, as well as ginger and turmeric, and advises conducting elimination diets only under supervision and with a food diary. This is an expert position, not a proof of efficacy for joint pain in menopause.
→ Expert source: Dr. Andrew Weil – Does Diet Trigger Arthritis Symptoms? (As of 28.04.2023)
Evidence Map: What plays a role in menopausal joint pain
| Approach | For what | State of evidence | What does not follow |
|---|---|---|---|
| Exercise and strength training | Pain and function in osteoarthritis | Cochrane 2024: 13.14 points better vs. no treatment (low certainty); moderate as an adjunct | No specific evidence for menopausal joint pain; clinical relevance uncertain |
| Weight loss | Osteoarthritis symptoms | Strong recommendation (ACR 2019); IQWiG: from 5 % | Applies only to excess weight; no magic bullet |
| Menopausal hormone therapy | Newly developed nonspecific joint pain with hormonal indication | Draft guideline 2026: “can be offered” (consensus-based); WHI: 76.3 % vs. 79.2 % with joint pain | Not a standard remedy; draft, not final; weigh risks individually |
| Heat, acupuncture | Short-term relief for osteoarthritis | Conditional recommendation (ACR 2019), modest benefit | No cure; data not menopause-specific |
| Over-the-counter painkillers (NSAIDs) | Acute pain spikes in osteoarthritis | Strong recommendation for temporary relief (ACR); IQWiG: effective | Not a permanent solution; observe side effects |
| Vitamin D and Omega-3 | Knee pain | VITAL sub-study: no effect after 5.3 years | Says nothing about bone health or confirmed deficiency |
| Collagen peptides | Osteoarthritis symptoms | Meta-analysis: mixed; total WOMAC better, pain sub-score not significant | No cartilage repair proven |
This overview is an evidence-based assessment and not an individual therapy recommendation.
The VEYT Joint Check: 5 steps in the right order
- Describe the pattern: Which joints hurt, is it on one side or both, and how long does morning stiffness last? A symptom diary kept for two to three weeks is sufficient.
- Take signs of inflammation seriously: Warm, swollen joints or stiffness lasting more than 30 minutes require a visit to a doctor; if there is a suspicion of rheumatism, consult a rheumatologist.
- Establish exercise as a foundation: Joint-friendly endurance training plus two strength training sessions per week; if overweight, weight loss is also recommended.
- Address the hormone question: If hot flashes, sleep disorders, or other menopausal symptoms are also present, discuss with your gynecologist whether hormone therapy (MHT) is an option.
- Use supplements only for targeted purposes: Take Vitamin D based on blood levels rather than on suspicion; there is no reliable evidence to support pain relief from Vitamin D, Omega-3, collagen, or glucosamine.
The VEYT product for this article
VEYT products can help compensate for a medically diagnosed nutrient deficiency. They are not a treatment for joint pain and are no substitute for exercise, medical clarification, or therapy. We intentionally highlight only one product: Vitamin D is an important topic in menopause for bone health, even if the research does not prove it provides pain relief. We are not showing products for Omega-3, collagen, or glucosamine here because the evidence regarding joint pain is insufficient.
VEYT Lumina D3 K2
Vegan drops with 1,000 IU of Vitamin D3 and Vitamin K2 (all-trans MK-7) per product labeling. Vitamin D contributes to the maintenance of normal bones. Suitable if a low Vitamin D level has been medically determined; this is not a remedy for joint pain.
View VEYT Lumina D3 K2 →Dietary supplements are not a substitute for a balanced diet or medical treatment. Please have your dosage confirmed by a doctor or pharmacist if you have known medical conditions or are taking medication.
Expert Perspectives & Protocol Breakdown
Dr. Eric Berg (Chiropractor, nutrition author)
What he recommends: In his article on estrogen in menopause, Berg mentions hot flashes, mood swings, vaginal dryness, loss of bone density, and changes in body composition. He does not specifically address joint pain there. As counter-measures, he recommends his low-carb "Healthy Keto" diet featuring cruciferous vegetables, leafy greens, and healthy fats, along with intermittent fasting, strength training, stress management, and sufficient sleep.
→ Expert source: Dr. Eric Berg – How Estrogen Levels Change During Menopause
Dr. Josh Axe (Nutrition and natural health author)
What he recommends: Under the heading of chronic pain, Axe describes six approaches: physical therapy, Eastern practices like yoga, acupuncture and tai chi, psychotherapy, relaxation techniques, CBD oil, as well as supplements and essential oils including turmeric, Omega-3, collagen and bone broth, magnesium Epsom salts, frankincense, and peppermint. The article does not mention menopause.
→ Expert source: Dr. Josh Axe – Chronic Pain Management: 6 Potential Natural Treatments
Dr. Andrew Weil (Physician, integrative medicine)
What he recommends: Weil sees "little evidence" for the nightshade-elimination diet, but acknowledges that inflammation in osteoarthritis might play a bigger role than previously thought. He advises an anti-inflammatory diet containing fatty fish, flaxseed, walnuts, colorful fruits and vegetables, ginger, and turmeric, and only recommends elimination diets under professional supervision with a food diary.
→ Expert source: Dr. Andrew Weil – Does Diet Trigger Arthritis Symptoms?
The Menopause Society (Faubion et al.) and AWMF guideline commission
What they advocate: The Menopause Society describes hormone therapy as a treatment to be weighed individually for vasomotor symptoms, genitourinary syndrome, and bone preservation. In its 2026 draft, the AWMF guideline commission suggests that for newly occurring, non-specific joint pain with hormonal indicators, MHT may be offered. Both sources are professional societies or committees, not individuals with their own protocols.
→ Sources: The 2022 hormone therapy position statement (Menopause Society) · AWMF 015-062 Consultation Draft 2026
Where They Differ
Berg, Axe, and Weil focus on diet and lifestyle and do not address the hormone question in the context of joint pain; none of the three distinguishes between arthralgia, osteoarthritis, and inflammatory rheumatism. Axe lists Omega-3, collagen, and turmeric as potential aids, whereas Weil emphasizes that many nutritional theories are poorly supported. The professional societies focus on medical clarification and the individual benefit-risk assessment of hormone therapy. Everyone agrees on one point: exercise, strength training, and a stable daily routine with enough sleep do no harm.
What the Evidence Says
Exercise is the most strongly supported (Cochrane 2024). For hormone therapy, there is a moderate, self-reported effect on the frequency of joint pain (WHI) and a consensus-based draft guideline. For Vitamin D and Omega-3, the VITAL sub-study showed no benefit for knee pain; collagen provides mixed results; glucosamine is controversial. The experts' nutrition-related recommendations remain expert opinion without direct data on joint pain during menopause.
What you should not believe about joint pain in menopause
"It’s always estrogen deficiency"
This is unproven. Estrogen is a plausible factor, but according to Roman-Blas and colleagues, the data on cartilage is contradictory, and osteoarthritis, rheumatism, obesity, and muscle weakness are equally likely causes.
"Hormones are the remedy for joint pain"
The draft guideline uses the phrasing "can be offered," not "should be." The WHI data shows a moderate decrease in frequency, but also slightly more joint swelling under estrogen.
"Collagen or glucosamine repair the cartilage"
Repair has not been proven. In the GAIT study, joint space width did not differ from placebo, and the collagen meta-analysis found no significant improvement in the WOMAC pain subscore.
"You should take it easy when you have joint pain"
The opposite is true. In the Cochrane review, exercise improved pain and function, and the ACR guideline recommends it as a basis. Being joint-friendly means training differently, not stopping altogether.
"Everything is over after menopause"
This cannot be stated as a general rule. In the meta-analysis by Lu and colleagues, the frequency in the peri- and post-menopause was similar, and moderate to severe pain was actually more frequent after menopause.
Conclusion: Assessing and acting on menopausal joint pain
Conclusion
Joint pain is common in menopause, but not automatically hormonal. Estrogen loss is a plausible factor, but it is not proven to be the sole cause. You should have signs of inflammation investigated, as osteoarthritis and rheumatoid arthritis require different approaches.
Exercise and strength training have the strongest evidence base. Hormone therapy may be considered for newly occurring joint discomfort with hormonal indicators, but according to the draft guideline, it is an open option and not the standard. Vitamin D and Omega-3 yielded no results for knee pain in the VITAL sub-study, collagen results are mixed, and glucosamine is controversial.
Going through the five steps of the VEYT Joint Check saves a lot of trial and error and gets you to the right place faster.
Frequently asked questions about joint pain in menopause
Menopause joint pain: What helps?
The best-supported treatments are exercise and strength training; if overweight, weight loss, as well as short-term heat and over-the-counter painkillers for osteoarthritis. Hormone therapy can be considered for newly occurring joint discomfort with hormonal indicators (2026 draft guideline, consensus-based). There is currently no robust evidence for the pain-relieving benefits of dietary supplements.
Menopause joint pain home remedies: What can I do myself?
Heat, gentle movement, joint-friendly endurance training, and two strength sessions per week are low-risk and worth trying. The ACR guideline conditionally recommends heat applications. We found no robust studies on wraps, poultices, or ointments for menopausal joint pain; they are not a substitute for medical clarification.
Can menopause joint pain be treated naturally?
In part. Exercise, strength training, heat, and weight loss (if overweight) are among the best-documented measures. Herbal remedies and supplements have unreliable evidence. Inflammatory causes like rheumatoid arthritis should not be treated naturally alone but should be clarified by a doctor.
Menopause joint pain supplements: Which ones have studies?
Vitamin D (2,000 IU) and Omega-3 (1 g) showed no effect on knee pain in the VITAL sub-study of 1,398 people after an average of 5.3 years. Collagen provides mixed results; glucosamine and chondroitin are inconsistently evaluated. We did not find a study specifically on menopausal joint pain for these substances.
Menopause joint pain collagen: Does it help?
Possibly a little, but it is not certain. A meta-analysis for osteoarthritis found an improvement of 8.00 points in the WOMAC total score and stiffness, but no significant difference in pain and function subscores. We did not find a study for menopause itself.
Menopause joint pain hormones: Do hormones help against joint pain?
Sometimes, to a moderate extent. In the Women's Health Initiative, 76.3% of women on estrogen had joint pain after one year compared to 79.2% on placebo, with slightly more frequent joint swelling. The 2026 draft guideline states that MHT may be offered for newly occurring non-specific joint discomfort with hormonal indicators.
Menopause joint pain hormone replacement therapy: Is it safe?
That depends on age, timing, and medical history. The Menopause Society considers the benefit-risk ratio favorable for women under 60 years of age or within ten years of menopause without contraindications. Risks for coronary heart disease, stroke, thrombosis, and dementia increase if started later. The decision belongs in the gynecological office.
Menopause joint pain medications: Which are common?
For osteoarthritis, over-the-counter painkillers like ibuprofen alleviate symptoms; the ACR guideline strongly recommends oral NSAIDs for temporary relief. They do not treat the cause and have side effects. For rheumatoid arthritis, treatment is managed by a rheumatologist. Please coordinate the dosage and duration with your doctor or pharmacist.
Menopause joint pain duration: How long does it last?
According to the data, no fixed duration can be given. In the meta-analysis by Lu et al., the frequency of muscle and joint pain was similar in peri- and post-menopause (OR 1.07); moderate to severe pain was even more frequent after menopause. If symptoms last longer than a few weeks, a doctor should take a look.
Menopause joint pain or rheumatism: How do I distinguish them?
Signs of rheumatism include warm, swollen joints, the same joints on both sides, fatigue, and morning stiffness lasting from more than 30 minutes to over an hour. Osteoarthritis tends to show starting pain and a gradual progression in the knee, hip, or fingers. A reliable distinction can only be made by a doctor; in case of suspected rheumatism, a rheumatologist is the right contact.
Menopause joint pain symptoms: How do I recognize them?
Typical signs are aching, stiff, or painful joints, often with muscle pain, such as in the knee, hip, and fingers. In studies, joint and muscle symptoms were usually recorded together; on average, 65.4% of middle-aged women reported them. Warm, swollen, or reddened joints point more toward an inflammatory cause and should be clarified by a doctor.
Continue reading on VEYT
- Glucosamine and Chondroitin for joint pain: What studies really show
- Glucosamine and Chondroitin: Effect, dosage, and studies on osteoarthritis
- MSM Effect: What studies show for joints and connective tissue
- Muscle loss in menopause: Creatine, protein, and strength training
- Preventing osteoporosis from age 50: What counts for strong bones
- Hot flashes in menopause: What studies and guidelines show
- Supplements in menopause: Magnesium, Vitamin D, and Ashwagandha
- Gentle training from age 40: Recovery-first fitness
References & Scientific Citations
- Fang Y et al. – Mapping global prevalence of menopausal symptoms among middle-aged women, BMC Public Health (2024)
- Lu C et al. – Musculoskeletal Pain during the Menopausal Transition: A Systematic Review and Meta-Analysis, Neural Plasticity (2020)
- Wright VJ et al. – The musculoskeletal syndrome of menopause, Climacteric (2024)
- Roman-Blas JA et al. – Osteoarthritis associated with estrogen deficiency, Arthritis Research & Therapy (2009)
- IQWiG – Rheumatoid Arthritis, gesundheitsinformation.de (As of 15.11.2023)
- IQWiG – Osteoarthritis, gesundheitsinformation.de (As of 25.06.2025)
- Lawford BJ et al. – Exercise for osteoarthritis of the knee, Cochrane Database of Systematic Reviews (2024)
- Buelt A, Narducci DM – Osteoarthritis Management: Updated Guidelines from the ACR and Arthritis Foundation, American Family Physician (2021)
- Chlebowski RT et al. – Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial, Menopause (2013)
- AWMF 015-062 – Summary 2026 (Consultation Version) of the S3 Guideline on Peri- and Postmenopause
- Faubion SS et al. – The 2022 hormone therapy position statement of The North American Menopause Society, Menopause (2022)
- MacFarlane LA et al. – Vitamin D and marine omega-3 fatty acid supplementation and chronic knee pain, Arthritis & Rheumatology (2020)
- García-Coronado JM et al. – Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials, International Orthopaedics (2019)
- NCCIH (NIH) – Glucosamine and Chondroitin for Osteoarthritis: What You Need To Know (As of October 2023)
- Dr. Andrew Weil – Does Diet Trigger Arthritis Symptoms?
- Dr. Eric Berg – How Estrogen Levels Change During Menopause
- Dr. Josh Axe – Chronic Pain Management: 6 Potential Natural Treatments
Transparency of Sources: The mentioned physicians and authors are used as sources of perspective. Statements regarding diagnosis and treatment are classified primarily based on guidelines, systematic reviews, meta-analyses, and randomized trials. The cited guideline recommendation E 2.15 comes from a consultation version (draft, as of June 2026) and is subject to change. Expert opinion, observational data, and clinical evidence of efficacy are not equated. This article was written independently; figures were verified against the linked original sources (as of October 2026).
